Answer
No specific animal fertility studies have evaluated pertuzumab, a component of Phesgo, although repeat-dose toxicity studies lasting up to six months in cynomolgus monkeys found no adverse effects on male or female reproductive organs.
Sources for this answer
- Phesgo 600 mg/600 mg, 1200 mg/600 mg solution for injectionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked